FDA Warning Letters: COVID Related Claims About Hemp Products

— Written By Marne Coit
en Español

El inglés es el idioma de control de esta página. En la medida en que haya algún conflicto entre la traducción al inglés y la traducción, el inglés prevalece.

Al hacer clic en el enlace de traducción se activa un servicio de traducción gratuito para convertir la página al español. Al igual que con cualquier traducción por Internet, la conversión no es sensible al contexto y puede que no traduzca el texto en su significado original. NC State Extension no garantiza la exactitud del texto traducido. Por favor, tenga en cuenta que algunas aplicaciones y/o servicios pueden no funcionar como se espera cuando se traducen.

English is the controlling language of this page. To the extent there is any conflict between the English text and the translation, English controls.

Clicking on the translation link activates a free translation service to convert the page to Spanish. As with any Internet translation, the conversion is not context-sensitive and may not translate the text to its original meaning. NC State Extension does not guarantee the accuracy of the translated text. Please note that some applications and/or services may not function as expected when translated.

Collapse ▲

6/1/2020 – Since the 2018 Farm Bill was signed into law, the Food and Drug Administration (FDA) has said that it has authority under the Federal Food, Drug, and Cosmetic Act (FD&C Act) to regulate food products and dietary supplements that contain CBD, as well as other products that contain CBD that make health claims. This extends to health claims made about CBD products and their ability to treat or prevent COVID-19. At this time, there are no hemp products that have been approved by FDA for these purposes. Statements making such claims are viewed by the FDA to be false or misleading, in violation of the FD&C Act.

The agency has issued warning letters to companies that make false or misleading claims about hemp and hemp-derived CBD products, and is evaluating company websites as well as the label on the products themselves. If companies do not comply with the terms of the warning letters and remove these claims, the FDA may take further action, including the seizure of products and/or an injunction against the company to stop them from selling such products.

Read more on the FDA’s website.